Biochemical and biophysical analysis of five disease-associated human adenylosuccinate lyase mutants
- PMID: 19405474
- PMCID: PMC2745324
- DOI: 10.1021/bi802321m
Biochemical and biophysical analysis of five disease-associated human adenylosuccinate lyase mutants
Abstract
Adenylosuccinate lyase (ASL), a catalyst of key reactions in purine biosynthesis, is normally a homotetramer in which three subunits contribute to each of four active sites. Human ASL deficiency is an inherited metabolic disease associated with autism and mental retardation. We have characterized five disease-associated ASL mutants: R194C and K246E are located at subunit interfaces, L311V is in the central helical region away from the active site, and R396C and R396H are at the entrance to the active site. The V(max) (at 25 degrees C) for R194C is comparable to that of WT, while those of L311V, R396C, R396H, and K246E are considerably reduced and affinity for adenylosuccinate is retained. The mutant enzymes have decreased positive cooperativity as compared to WT. K246E exists mainly as dimer or monomer, accounting for its negligible activity, whereas the other mutant enzymes are similar to WT in the predominance of tetramer. At 37 degrees C, the specific activity of WT and these mutant enzymes slowly decreases 30-40% with time and reaches a limiting specific activity without changing significantly the amount of tetramer. Mutant R194C is unique in being rapidly inactivated at the harsher temperature of 60 degrees C, indicating that it is the least stable enzyme in vitro. Conformational changes in the mutant enzymes are evident from protein fluorescence intensity at 25 degrees C and after incubation at 37 degrees C, which correlates with the loss of enzymatic activity. Thus, these disease-associated single mutations can yield enzyme with reduced activity either by affecting the active site or by perturbing the enzyme's structure and/or native conformation which are required for catalytic function.
Figures
References
-
- Ratner S. Argininosuccinases and adenylosuccinases. In: Boyer PD, editor. The Enzymes. 3rd Ed Vol. 7. Academic Press, Inc.; New York: 1972. pp. 167–197.
-
- Bridger WA, Cohen LH. The kinetics of adenylosuccinate lyase. J. Bio. Chem. 1968;243:644–650. - PubMed
-
- Bulusu V, Srinivasan B, Bopanna MP, Balaram H. Elucidation of the substrate specificity, kinetic and catalytic mechanism of adenylosuccinate lyase from Plasmodium falciparum. Biochim. et Biophys Acta. 2009;1794:642–654. - PubMed
-
- Nuiry I, Hermes JD, Weiss PM, Chen C-Y, Cook PF. Kinetic mechanism and location of rate-determining steps for aspartase from Hafnia alvei. Biochemistry. 1984;23:5168–5175. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
